UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013060
Receipt number R000015165
Scientific Title The efficacy of the eradication of Helicobacter pylori for quality of life -Multicenter clinical study-
Date of disclosure of the study information 2014/02/03
Last modified on 2016/03/20 10:24:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of the eradication of Helicobacter pylori for quality of life
-Multicenter clinical study-

Acronym

Kagoshima pylori study

Scientific Title

The efficacy of the eradication of Helicobacter pylori for quality of life
-Multicenter clinical study-

Scientific Title:Acronym

Kagoshima pylori study

Region

Japan


Condition

Condition

Helicobacter infection without other orgnic disease

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Since H. pylori infection as well as the digestive tract associated with blood disorders, allergic diseases etc. have been reported, the possibility that inhibit QOL potentially some influence on various fields. Upper abdominal symptoms caused by H. pylori infection if the cause of QOL inhibition, improvement of QOL by eradication can be expected of course. However, there are few reports that whether H. pylori eradication improved QOL of patients without upper abdominal symptoms. By performing the eradication of the patients with or without upper abdominal symptoms, we will be able to build a new evidence of H. pylori eradication.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of quality of life before and after Helicbacter pylori eradication

Key secondary outcomes

1.Effect of full dose of administration of proton pump inhibitor for upper abdominal symptoms in before and after eradication of Helicobacter pylori.
2.Evaluation of the successful rate of eradication of Helicobacter pylori by preceding PPI administration before eradication.


Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

For upper abdominal symptoms of Helicobacter pylori (H. pylori) infected patients, proton pump inhibitor (PPI) are administrated before the eradication of H. pylori. If the upper abdominal symptoms were not improved after the eradication therapy, further administration of PPI are done .

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are not administrated proton pump inhibitor (PPI) or administrated half dose of PPI.
Patients who are diagnosed atrophic gastritis with endoscopy.

Key exclusion criteria

Patients who are not diagnosed gastro-esophageal reflux disease (GERD) over the grade A of Los Angeles Classification, gastric ulcer, gastric cancer.
Patients who are not administrated non steroidal anti-inflammatory drugs (NSAIDs), major or minor tranquilizer, acotiamide every day.
Patients with history of gastrectomy.
Patients with severe renal or liver dysfunciton.
Patients with cancer.
Patients who have a history of failure of the first eradication of Helicobacter pylori.

Target sample size

230


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroki Taguchi

Organization

Kagoshima University Graduate School of Medical and Dental Sciences

Division name

Digestive and Life-style related Disease

Zip code


Address

8-35-1 Sakuragaoka, Kagoshima, Japan

TEL

099-275-5326

Email

tag@m2.kufm.kagoshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroki Taguchi

Organization

Kagoshima University Graduate School of Medical and Dental Sciences

Division name

Digestive and Life-style related Disease

Zip code


Address

8-35-1 Sakuragaoka, Kagoshima, Japan

TEL

099-275-5326

Homepage URL


Email

tag@m2.kufm.kagoshima-u.ac.jp


Sponsor or person

Institute

Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Life-style related Disease

Institute

Department

Personal name



Funding Source

Organization

Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Life-style related Disease

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 02 Month 03 Day

Last modified on

2016 Year 03 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015165


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name